In-License of Paracetamol 500mg Dossier

Phase

due diligence

Deal Value

$250,000.00

milestone

End Date

January 14th, 2025

Key Milestone

October 15th, 2024

Project Details

Supplier

Lead Department

Start Date

January 15th, 2024

End Date

January 14th, 2025

Financial Terms

milestone

Renewal Term

none

Project ID

PXG-LIC-2024-001

Dossier Status

under review

Description

In-licensing project for a generic Paracetamol 500mg tablet for the EU market.

Project History

Dossier Review Hub

Track due diligence progress across key departments.

Business Development

Dr. Eva Reinhardt - almost 2 years ago

Commercial terms look favorable.

Regulatory Affairs

Dr. Klaus Richter - almost 2 years ago

CMC section requires clarification from supplier.

R&D

Supply Chain

Legal & IP

Sophia Ziegler - almost 2 years ago

Freedom-to-operate analysis is blocked pending response from supplier on manufacturing process.

Attachments

All related documents.